surmount-1 tirzepatide trial obesity without diabetes 🤔Adults with type 2 and lose less weight on EVERY GLP-1 drug compared to those diabetes, consistently ~5% less. Now that we have retatrutide's TRIUMPH-2 data today we can tirzepatide surmount once weekly for

The trade-off: more injections per week and no clinical trial data validating this approach

Choline and methionine act as methyl donors, and the stated rationale is supporting hepatic fatty acid oxidation, mitochondrial function and lipid transport

The resulting blend has been shown in clinical research to boost and sustain muscle-pumping nitric oxide levels more effectively than glutathione or L-Citrulline alone, which in turn has been suggested to enhance aerobic exercise performance

[4] While common, it is important to note that these events are generally mildtomoderate, and they are also often transient, occurring most frequently during or shortly after dose escalation

Woehlbier et al., 2016)